IL15 and neoplasm: Although previous evidences have demonstrated the efficacy of NK cells used as a single agent in adoptive immunotherapy or in tumor-specific mAbs treatment, the proliferation and persistence enhancement of such NK cells in vivo can be contributed by the combination effects of cytokines, e.g. IL-12, IL-15 and IL-21.